Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
<a href="https://www.fiercebiotech.com/medtech/solventum-buy-acera-surgical-850m-repurchase-1b-stock" hreflang="en">Solventum to buy Acera Surgical for up to $850M, repurchase $1B in stock</a>
Solventum, which spun out of 3M nearly two years ago, will shell out up to $850 million for wound care specialist Acera Surgical in its first major acquisition.
Novartis was the sole bidder in $12B deal to buy Avidity
It took 14 calls between chief executives, four months of negotiations and four hiked proposals for Novartis and Avidity Biosciences to come to their $12 billion agreem...
Lonza Group Ltd: Strong Growth Prospects and Attractive Valuation Support Buy Rating - TipRanks
Lonza Group Ltd: Strong Growth Prospects and Attractive Valuation Support Buy Rating TipRanks
Handelsbanken Fonder AB Buys 7,524 Shares of Agilent Technologies, Inc. $A - MarketBeat
Handelsbanken Fonder AB Buys 7,524 Shares of Agilent Technologies, Inc. $A MarketBeat
UBS Sticks to Its Buy Rating for Roche Holding AG (RHHVF) - The Globe and Mail
UBS Sticks to Its Buy Rating for Roche Holding AG (RHHVF) The Globe and Mail
Is Agilent Technologies Inc. (AG8) stock prepared for digital transition - Weekly Investment Recap & AI Based Buy and Sell Signals - newser.com
Is Agilent Technologies Inc. (AG8) stock prepared for digital transition - Weekly Investment Recap & AI Based Buy and Sell Signals newser.com
Is Illumina Inc. (ILU) stock a buy on weakness - Portfolio Performance Report & Accurate Buy Signal Alerts - newser.com
Is Illumina Inc. (ILU) stock a buy on weakness - Portfolio Performance Report & Accurate Buy Signal Alerts newser.com
Thermo Fisher Scientific (TMO): Evaluating Valuation After $5 Billion Share Buyback Announcement - simplywall.st
Thermo Fisher Scientific (TMO): Evaluating Valuation After $5 Billion Share Buyback Announcement simplywall.st
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact - Yahoo Finance
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact Yahoo Finance
Thermo Fisher to buy Clario for $8.8bn - Clinical Trials Arena
Thermo Fisher to buy Clario for $8.8bn Clinical Trials Arena
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion - Reuters
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion Reuters